The 2014 Fall newsletter is here with important updates on our Selumetinib clinical trial, the Ruane Family's invovlement in ITOG, an update on the Annual Meeting, affiliation with the European Organization for Research and Treatment of Cancer (EORTC), updates on the Cabozantinib clinical trial, and a remembrance of Rick Abrams.  See the full newsletter in PDF by following this link: